Authors/Disclosures
|
Kevin B. Huang
(Yale School of Medicine)
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
Jacqueline A. Leavitt, MD
|
No disclosure on file |
|
Elaine Kingwell, MD, PhD
(University College London)
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
Belinda Nhundu
(Yale School of Medicine)
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
Kevin N. Sheth, MD, FAAN
(Yale UniversityDivision of Neuro and Critical Care)
|
Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceribell. Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Zoll. Dr. Sheth has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NControl. Dr. Sheth has received stock or an ownership interest from Astrocyte. Dr. Sheth has received stock or an ownership interest from Alva. The institution of Dr. Sheth has received research support from Biogen. The institution of Dr. Sheth has received research support from Novartis. The institution of Dr. Sheth has received research support from Bard. The institution of Dr. Sheth has received research support from Hyperfine. Dr. Sheth has received intellectual property interests from a discovery or technology relating to health care. |
|
David Y. Hwang, MD, FAAN
(University of North Carolina School of Medicine)
|
The institution of Dr. Hwang has received research support from NIH. The institution of Dr. Hwang has received research support from Neurocritical Care Foundation. Dr. Hwang has received personal compensation in the range of $10,000-$49,999 for serving as a Associate Medical Director with New England Donor Services. |